Johan M. van Rooijen

Author

Also Known As

B. C. M. Haberkorn, J. M. Van Rooijen, J. M. van Rooijen, J.M. Van Rooijen, J.M. van Rooijen, Johan M. van Rooijen, van Rooijen, Johan M.

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Martini Ziekenhuis The Netherlands Cancer Institute Isala University of Groningen Northwest Hospital

About

Johan M. van Rooijen is an author at Martini Ziekenhuis specializing in medicine, breast cancer, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	1.6K
2	Public Health	1	1	32
3	Anatomy	1	1	32
4	Cell Biology	1	1	23
5	Immunology	1	1	23

Johan M. van Rooijen

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial Renu R. Bahadoer, Esmée A. Dijkstra, Boudewijn van Etten, The Lancet Oncology Surgical OncologyRadiation TherapyGastrointestinal OncologyMedicineColorectal Cancer	2020	1.5K
Randomized phase III trial of S-1 versus capecitabine in the first-line treatment of metastatic colorectal cancer: SALTO study by the Dutch Colorectal Cancer Group Johannes J.M. Kwakman, Lieke H. J. Simkens, Johan M. van Rooijen, Annals of Oncology	2017	81
Whole genome sequencing of metastatic colorectal cancer reveals prior treatment effects and specific metastasis features Pauline A.J. Mendelaar, Marcel Smid, Job van Riet, Nature Communications	2021	79
Feasibility and effectiveness of trifluridine/tipiracil in metastatic colorectal cancer: real-life data from The Netherlands Johannes J.M. Kwakman, Geraldine R. Vink, J.H.M.J. Vestjens, International Journal of Clinical Oncology	2017	38
Left atrial impression: a sign of extra-cardiac pathology Johan M. van Rooijen, Lambert F.M. van den Merkhof European Journal of Echocardiography Heart FailureStructural Heart DiseaseCardiovascular DiseaseCardiac MechanicPhysiology	2008	32
Androgen receptor expression inversely correlates with immune cell infiltration in human epidermal growth factor receptor 2–positive breast cancer Johan M. van Rooijen, Si-Qi Qiu, Hetty Timmer‐Bosscha, European Journal of Cancer Breast OncologyMedicineHormonal ReceptorImmunologyTumor Immunity	2018	23
Hydrocephalus, a Rare Manifestation of Sarcoidosis Johan M. van Rooijen, G. Sophie Mijnhout, Tom T.A. Aalders, Clinics and Practice Clinical FindingSymptomatic HydrocephalusPediatric Hydrocephalus36-Week-pregnant WomanPathology	2011	21
Tolerance-based capecitabine dose escalation after DPYD genotype-guided dosing in heterozygote DPYD variant carriers Jan P. Kleinjan, Ithamar Brinkman, Robbert Bakema, Anti-Cancer Drugs	2019	13
Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours Birgit S. Geurts, Thomas Battaglia, Jade M. van Berge Henegouwen, BMC Cancer	2023	12
Limited human epidermal growth factor receptor 2 discordance in metastatic breast cancer patients treated with trastuzumab, a population based study Johan M. van Rooijen, L. de Munck, Jacques C. de Graaf, European Journal of Cancer Breast OncologyMedicinePathologyImmune Checkpoint InhibitorBreast Cancer	2014	10

Page 1